44. Design Thinking in Biotech w/ Chris Garabedian - CEO @ Xontogeny / Former CEO @ Sarepta
Jun 20, 2022
auto_awesome
Join Chris Garabedian, Chairman & CEO of Xontogeny, as he discusses strategic design choices in early drug development in biotech, optimizing biotech investments for success, and the future of precision medicine in the industry. Learn about his transition from marketing to biopharmaceuticals, the power of analytical thinking, and the importance of mentorship in driving innovation.
Leadership in biotech requires analytical skills, effective communication, and strategic vision.
Market research expertise can be successfully applied to pharmaceutical research.
Design choices in drug development impact success by anticipating challenges and optimizing decisions.
Deep dives
BIOS Community: A Platform for Healthcare and Life Sciences Founders and Investors
BIOS is a community that curates content, hosts events, and fosters collaboration among early stage healthcare and life sciences founders and investors. Anchored by Alex Ventress, BIOS offers resources and a community for startups in San Francisco, emphasizing collaboration and support.
Chris Garibedian's Diverse Career in Biopharmaceuticals and Venture Investing
Chris Garibedian shares his journey spanning over 30 years in biopharmaceuticals, transitioning from roles in operating companies to investor collaboration. As a CEO and investor, he led successful programs focusing on rare diseases, showcasing significant achievements in drug development and venture investing.
Educational Background and Career Path in Biopharmaceuticals
Chris Garibedian's bachelor's degree in marketing led him to the biopharmaceutical industry through market research consulting. His expertise in market research techniques and statistical methodologies translated well into pharmaceutical research, enabling a comprehensive understanding of drug development and strategic decision-making.
The Importance of Analytical Skills and Communication in Leadership
Garibedian highlights the value of analytical capabilities, communication skills, and maintaining a big-picture view in leadership roles. Effective communication, coupled with expertise in the subject matter, enhances credibility and persuasiveness. Understanding the 'why' behind decisions and continuously learning contribute to success in leadership.
Design Thinking and Drug Development for Future Success
Garibedian emphasizes the significance of design choices in drug development, focusing on strategic experiment design, regulatory strategies, and commercial viability considerations. By adopting a proactive approach to anticipate challenges and optimize decision-making, companies can enhance their likelihood of success in clinical development and create value.
Navigating Talent and Precision Medicine in Biotechnology's Future
The future of biotechnology envisions advancements in personalized medicine, precision therapies, and combinatorial approaches. Addressing talent gaps and encouraging precision medicine adoption will shape the industry's evolution. Garibedian anticipates a shift towards precision therapies and optimized disease treatments by 2050, driven by scientific advancements and strategic drug development.
Chris Garabedian is the Chairman & CEO of Xontogeny where he supports companies with cutting-edge technologies from early development through clinical proof of concept. Chris has decades of leadership experience in the biopharmaceutical industry. From 2011 to 2015, Chris led the turnaround of Sarepta Therapeutics as CEO. Prior to that, Chris served as VP of Corporate Strategy at Celgene and has held multiple executive roles at Gilead across corporate development, marketing, and medical affairs. Chris started his career in the biopharmaceutical industry as a consultant and holds a BS in Marketing from the University of Maryland.
Thank you for listening!
BIOS (@BIOS_Community) unites a community of Life Science innovators dedicated to driving patient impact. Alix Ventures (@AlixVentures) is a San Francisco based venture capital firm supporting early stage Life Science startups engineering biology to create radical advances in human health.
Music: Danger Storm by Kevin MacLeod (link & license)
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
